| [1] |
Drüeke TB, Massy ZA. Beta2-microglobulin [J]. Semin Dial, 2009, 22(4): 378-380.
|
| [2] |
Floege J, Bartsch A, Schulze M, et al. Clearance and synthesis rates of beta 2-microglobulin in patients undergoing hemodialysis and in normal subjects [J]. J Lab Clin Med, 1991, 118(2): 153-165.
|
| [3] |
Kaneko S, Yamagata K. Hemodialysis-related amyloidosis: is it still relevant? [J]. Semin Dial, 2018, 31(6): 612-618.
|
| [4] |
Winchester JF, Salsberg JA, Levin NW. Beta-2 microglobulin in ESRD: an in-depth review [J]. Adv Ren Replace Ther, 2003, 10(4): 279-309.
|
| [5] |
Sonikian M, Gogusev J, Zingraff J, et al. Potential effect of metabolic acidosis on beta 2-microglobulin generation: in vivo and in vitro studies [J]. J Am Soc Nephrol, 1996, 7(2): 350-356.
|
| [6] |
Odell RA, Slowiaczek P, Moran JE, et al. Beta2-microglobulin kinetics in end-stage renal failure [J]. Kidney Int, 1991, 39(5): 909-919.
|
| [7] |
Cheung AK, Rocco MV, Yan G, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study [J]. J Am Soc Nephrol, 2006, 17(2): 546-555.
|
| [8] |
Cheung AK, Greene T, Leypoldt JK, et al. Association between serum beta 2-microglobulin level and infectious mortality in hemodialysis patients [J]. Clin J Am Soc Nephrol, 2008, 3(1): 69-77.
|
| [9] |
Liabeuf S, Lenglet A, Desjardins L, et al. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients [J]. Kidney Int, 2012, 82(12): 1297-1303.
|
| [10] |
Gejyo F, Yamada T, Odani S, et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin [J]. Biochem Biophys Res Commun, 1985, 129(3): 701-706.
|
| [11] |
Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines [J]. Amyloid, 2016, 23(4): 209-213.
|
| [12] |
Koch KM. Dialysis-related amyloidosis [J]. Kidney Int, 1992, 41(5): 1416-1429.
|
| [13] |
Jadoul M, Garbar C, No LH, et al. Histological prevalence of β2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study [J]. Kidney Int, 1997, 51(6): 1928-1932.
|
| [14] |
Scarpioni R, Ricardi M, Albertazzi V, et al. Dialysis-related amyloidosis: challenges and solutions [J]. Int J Nephrol Renovasc Dis, 2016, 9: 319-328.
|
| [15] |
Motomiya Y, Higashimoto Y, Uji Y, et al. C-terminal unfolding of an amyloidogenic beta2-microglobulin fragment: deltaN6beta2-microglobulin [J]. Amyloid, 2015, 22(1): 54-60.
|
| [16] |
Miyata T, Oda O, Inagi R, et al. Beta2－microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis [J]. J Clin Invest, 1993, 92(3): 1243-1252.
|
| [17] |
Miyata T, Inagi R, Iida Y, et al. Involvement of beta2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1 [J]. J Clin Invest, 1994, 93(2): 521-528.
|
| [18] |
Morimoto H, Wada J, Font B, et al. Procollagen C-proteinase enhancer-1 (PCPE-1) interacts with beta2-microglobulin (beta2-m) and may help initiate beta2-m amyloid fibril formation in connective tissues [J]. Matrix Biol, 2008, 27(3): 211-219.
|
| [19] |
Nybo M, Nielsen EH, Svehag SE. Complement activation by the amyloid proteins A beta peptide and beta2-microglobulin [J]. Amyloid, 1999, 6(4): 265-272.
|
| [20] |
Heegaard NH. Beta2-microglobulin: from physiology to amyloidosis [J]. Amyloid, 2009, 16(3): 151-173.
|
| [21] |
Menaa C, Esser E, Sprague SM. Beta2-microglobulin stimulates osteoclast formation [J]. Kidney Int, 2008, 73(11): 1275-1281.
|
| [22] |
Floege J, Ketteler M. Beta2-microglobulin-derived amyloidosis: an update [J]. Kidney Int Suppl, 2001, 78: S164-S171.
|
| [23] |
Hayami N, Hoshino J, Suwabe T, et al. Destructive spondyloarthropathy in patients on long-term peritoneal dialysis or hemodialysis [J]. Ther Apher Dial, 2015, 19(4): 393-398.
|
| [24] |
Kazama JJ, Yamamoto S, Takahashi N, et al. A beta-2M-amyloidosis and related bone diseases [J]. J Bone Miner Metab, 2006, 24(2): 182-184.
|
| [25] |
Takayama F, Miyazaki S, Morita T, et al. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients [J]. Kidney Int Suppl, 2001, 78: S172-S176.
|
| [26] |
Otsubo S, Kimata N, Okutsu I, et al. Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years [J]. Nephrol Dial Transplant, 2009, 24(5): 1593-1598.
|
| [27] |
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease [J]. Am J Kidney Dis, 2003, 42(4 Suppl 3): S1-S201.
|
| [28] |
Garbar C, Jadoul M, Noel H, et al. Histological characteristics of sternoclavicular beta2-microglobulin amyloidosis and clues for its histogenesis [J]. Kidney Int, 1999, 55(5): 1983-1990.
|
| [29] |
Donadio C, Kanaki A, Sami N, et al. High-flux dialysis: clinical, biochemical, and proteomic comparison with low-flux dialysis and on-line hemodiafiltration [J]. Blood Purificat, 2017, 44(2): 129-139.
|
| [30] |
Schiffl H. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients [J]. Hemodial Int, 2014, 18(1): 136-141.
|
| [31] |
Lornoy W, Becaus I, Billiouw JM, et al. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations [J]. Nephrol Dial Transplant, 2000, 15(Suppl 1): 49-54.
|
| [32] |
Raj DS, Ouwendyk M, Francoeur R, et al. Beta 2-microglobulin kinetics in nocturnal haemodialysis [J]. Nephrol Dial Transplant, 2000, 15(1): 58-64.
|
| [33] |
Gejyo F, Amano I, Ando T, et al. Survey of the effects of a column for adsorption of beta2-microglobulin in patients with dialysis-related amyloidosis in Japan [J]. Ther Apher Dial, 2013, 17(1): 40-47.
|
| [34] |
Zaoui PM, Stone WJ, Hakim RM. Effects of dialysis membranes on beta 2-microglobulin production and cellular expression [J]. Kidney Int, 1990, 38(5): 962-968.
|
| [35] |
Schwalbe S, Holzhauer M, Schaeffer J, et al. Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis? [J]. Kidney Int, 1997, 52(4): 1077-1083.
|
| [36] |
Bardin T, Lebail-Darne JL, Zingraff J, et al. Dialysis arthropathy: outcome after renal transplantation [J]. Am J Med, 1995, 99(3): 243-248.
|
| [37] |
Montagna G, Cazzulani B, Obici L, et al. Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis [J]. Amyloid, 2013, 20(3): 173-178.
|